HDL biogenesis and cellular cholesterol homeostasis

References

• Brown M. S., Goldstein J. L. A receptor‐mediated pathway for cholesterol homeostasis. Science 1986; 232: 34–47
   PubMed Web of Science ®Google Scholar
• Brown M. S., Goldstein J. L. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci U S A 1999; 96: 11041–8
   PubMed Web of Science ®Google Scholar
• Horton J. D., Goldstein J. L., Brown M. S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002; 109: 1125–31
   PubMed Web of Science ®Google Scholar
• Fielding C. J., Fielding P. E. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995; 36: 211–28
   PubMed Web of Science ®Google Scholar
• Gordon D. J., Rifkind B. M. High density lipoprotein—The clinical implications of recent studies. New Eng J Med 1989; 321: 1311–6
   PubMed Web of Science ®Google Scholar
• Ho Y. K., Brown M. S., Goldstein J. L. Hydrolysis and excretion of cytoplasmic cholesterol esters by macrophages: Stimulation by high density lipoprotein and other agents. J Lipid Res 1980; 21: 391–8
   PubMed Web of Science ®Google Scholar
• Oram J. F., Yokoyama S. Apolipoprotein‐mediated removal of cellular cholesterol and phospholipids. J Lipid Res 1996; 37: 2473–91
   PubMed Web of Science ®Google Scholar
• Yokoyama S. Apolipoprotein‐mediated cellular cholesterol efflux. Biochim Biophys Acta 1998; 1392: 1–15
   PubMed Web of Science ®Google Scholar
• Yokoyama S. Release of cellular cholesterol: Molecular mechanism for cholesterol homeostasis in cells and in the body. Biochim Biophys Acta 2000; 1529: 231–44
   PubMed Web of Science ®Google Scholar
• Glomset J. A. The lecithin: cholesterol acyltransferase reaction. J Lipid Res 1968; 9: 155–67
   PubMed Web of Science ®Google Scholar
• Czarnecka H., Yokoyama S. Lecithin: cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein‐mediated efflux. Biochemistry 1995; 34: 4385–92
   Google Scholar
• Czarnecka H., Yokoyama S. Regulation of cellular cholesterol efflux by lecithin: cholesterol acyltransferase reaction through nonspecific lipid exchange. J Biol Chem 1996; 271: 2023–8
   PubMed Web of Science ®Google Scholar
• Ji Y., Jian B., Wang N., Sun Y., Moya M. L., Phillips M. C., et al. Scavenger receptor BI promotes high density lipoprotein‐mediated cellular cholesterol efflux. J Biol Chem 1997; 272: 20982–5
   PubMed Web of Science ®Google Scholar
• de La Llera‐Moya M., Connelly M. A., Drazul D., Klein S. M., Favari E., Yancey P. G., et al. Scavenger receptor class B type I affects cholesterol homeostasis by magnifying cholesterol flux between cells and HDL. J Lipid Res 2001; 42: 1969–78
   Google Scholar
• Liu T., Krieger M., Kan H. Y., Zannis V. I. The effects of mutations in helices 4 and 6 of ApoA‐I on scavenger receptor class B type I (SR‐BI)‐mediated cholesterol efflux suggest that formation of a productive complex between reconstituted high density lipoprotein and SR‐BI is required for efficient lipid transport. J Biol Chem 2002; 277: 21576–84
   PubMedGoogle Scholar
• Chroni A., Nieland T. J., Kypreos K. E., Krieger M., Zannis V. I. SR‐BI mediates cholesterol efflux via its interactions with lipid‐bound ApoE. Structural mutations in SR‐BI diminish cholesterol efflux. Biochemistry 2005; 44: 13132–43
   PubMedGoogle Scholar
• Wang N., Lan D., Chen W., Matsuura F., Tall A. R. ATP‐binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high‐density lipoproteins. Proc Natl Acad Sci U S A 2004; 101: 9774–9
   PubMed Web of Science ®Google Scholar
• Hara H., Yokoyama S. Interaction of free apolipoprotein with macrophages: Formation of high density lipoprotein‐like lipoproteins and reduction of cellular cholesterol. J Biol Chem 1991; 266: 3080–6
   PubMed Web of Science ®Google Scholar
• Forte T. M., Goth‐Goldstein R., Nordhausen R. W., McCall M. R. Apolipoprotein A‐I‐cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles. J Lipid Res 1993; 34: 317–24
   PubMed Web of Science ®Google Scholar
• Forte T. M., Bielicki J. K., Knoff L., McCall M. R. Structural relationships between nascent apoA‐I‐containing particles that are extracellularly assembled in cell culture. J Lipid Res 1996; 37: 1076–85
   Google Scholar
• Forte T. M., Bielicki J. K., Goth‐Goldstein R., Selmek J., McCall M. R. Recruitment of cell phospholipids and cholesterol by apolipoproteins A‐II and A‐I: formation of nascent apolipoprotein‐specific HDL that differ in size, phospholipid composition, and reactivity with LCAT. J Lipid Res 1995; 36: 148–57
   PubMed Web of Science ®Google Scholar
• Hara H., Hara H., Komaba A., Yokoyama S. α‐Helical requirements for free apolipoproteins to generate HDL and to induce cellular lipid efflux. Lipids 1992; 27: 302–4
   Google Scholar
• Yancey P. G., Bielicki J. K., Johnson W. J., Lund‐Katz S., Palgunachari M. N., Anantharamaiah G. M., et al. Efflux of cellular cholesterol and phospholipid to lipid‐free apolipoproteins and class A amphipathic peptides. Biochemistry 1995; 34: 7955–65
   Google Scholar
• Mendez A. J., Anantharamaiah G. M., Segrest J. P., Oram J. F. Synthetic amphipathic helical peptides that mimic apolipoprotein A‐I in clearing cellular cholesterol. J Clin Invest 1994; 94: 1698–705
   PubMed Web of Science ®Google Scholar
• Remaley A. T., Thomas F., Stonik J. A., Demosky S. J., Bark S. E., Neufeld E. B., et al. Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1‐dependent and an ABCA1‐independent pathway. J Lipid Res 2003; 44: 828–36
   PubMed Web of Science ®Google Scholar
• Francis G. A., Knopp R. H., Oram J. F. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A‐I in Tangier disease. J Clin Invest 1995; 96: 78–87
   PubMed Web of Science ®Google Scholar
• Remaley A. T., Schumacher U. K., Stonik J. A., Farsi B. D., Nazih H. B., Brewer H. B. J. Decreased reverse cholesterol transport from Tangier disease fibroblasts: Acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler Thromb Vasc Biol 1997; 17: 1813–21
   Google Scholar
• Brooks‐Wilson A., Marcil M., Clee S. M., Zhang L‐H., Roomp K., van Dam M., et al. Mutations in ABC1 in tangier disease and familial high‐density lipoprotein deficiency. Nat Genet 1999; 22: 336–45
   PubMed Web of Science ®Google Scholar
• Bodzioch M., Orso E., Klucken J., Langmann T., Bottcher A., Diederrich W., et al. The gene encoding ATP‐binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 1999; 22: 347–51
   PubMed Web of Science ®Google Scholar
• Rust S., Rosier M., Funke H., Real J., Amoura Z., Piette J‐C., et al. Tangier disease is caused by mutations in the gene encoding ATP binding‐cassette transporter 1. Nat Genet 1999; 22: 352–5
   PubMed Web of Science ®Google Scholar
• Lawn R. M., Wade D. P., Garvin M. R., Wang X., Schwartz K., Porter J. G., et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein‐mediated lipid removal pathway. J Clin Invest 1999; 104: R25–R31
   PubMed Web of Science ®Google Scholar
• Remaley A. T., Rust S., Rosier M., Knapper C., Naudin L., Broccardo C., et al. Human ATP‐binding cassette transporter 1 (ABC1): Genomic organization and identification of the genetic defect in the original Tangier disease kindred. Proc Natl Acad Sci U S A 1999; 96: 12685–90
   PubMedGoogle Scholar
• Marcil M., Brooks‐Wilson A., Clee S. M., Roomp K., Zhang L. H., Yu L., et al. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet 1999; 354: 1341–6
   PubMed Web of Science ®Google Scholar
• Orso E., Broccardo C., Kaminski W. E., Böttcher A., Liebisch G., Drobnik W., et al. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and abc1‐deficient mice. Nat Genet 2000; 24: 192–6
   PubMed Web of Science ®Google Scholar
• McNeish J., Aiello R. J., Guyot D., Turi T., Gabel C., Aldinger C., et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP‐binding cassette transporter‐1. Proc Natl Acad Sci U S A 2000; 97: 4245–50
   PubMed Web of Science ®Google Scholar
• Abe‐Dohmae S., Suzuki S., Wada Y., Aburatani H., Vance D. E., Yokoyama S. Characterization of apolipoprotein‐mediated HDL generation induced by cAMP in a murine macrophage cell line. Biochemistry 2000; 39: 11092–9
   PubMed Web of Science ®Google Scholar
• Oram J. F., Lawn R. M., Garvin M. R., Wade D. P. ABCA1 is the cAMP‐inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem 2000; 275: 34508–11
   PubMed Web of Science ®Google Scholar
• Tajima S., Yokoyama S., Yamamoto A. Effect of lipid particle size on association of apolipoproteins with lipid. J Biol Chem 1983; 258: 10073–82
   Google Scholar
• Okabe H., Yokoyama S., Yamamoto A. Modulation of cholesterol microenvironment with apolipoproteins induced by the presence of cholesteryl ester in lipid microemulsion. J Biochem 1988; 104: 141–8
   Google Scholar
• Liang H‐Q., Rye K‐A., Barter P. J. Dissociation of lipid‐free apolipoprotein A‐I from high density lipoproteins. J Lipid Res 1994; 35: 1187–99
   Google Scholar
• Liang H‐Q., Rye K‐A., Barter P. J. Cycling of apolipoprotein A‐I between lipid‐associated and lipid‐free pools. Biochim Biophys Acta 1995; 1257: 31–7
   PubMed Web of Science ®Google Scholar
• Clay M. A., Newnham H. H., Forte T. M., Barter P. I. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A‐I from HDL and subsequent formation of discoidal HDL. Biochim Biophys Acta 1992; 1124: 52–8
   PubMed Web of Science ®Google Scholar
• Pussinen P., Jauhiainen M., Metso J., Tyynela J., Ehnholm C. Pig plasma phospholipid transfer protein facilitates HDL interconversion. J Lipid Res 1995; 36: 975–85
   Google Scholar
• Wolfbauer G., Albers J. J., Oram J. F. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high‐density lipoprotein apolipoproteins. Biochim Biophys Acta 1999; 1439: 65–76
   Google Scholar
• Komaba A., Li Q., Hara H., Yokoyama S. Resistance of smooth muscle cells to assembly of high density lipoproteins with extracellular free apolipoproteins and to reduction of intracellularly accumulated cholesterol. J Biol Chem 1992; 267: 17560–6
   Google Scholar
• Okuhira K., Tsujita M., Yamauchi Y., Abe‐Dohmae S., Kato K., Handa T., et al. Potential involvement of dissociated apoA‐I in the ABCA1‐dependent cellular lipid release by HDL. J Lipid Res 2004; 45: 645–52
   Google Scholar
• Bell‐Quint J., Forte T. Time‐related changes in the synthesis and secretion of very low density, low density and high density lipoproteins by cultured rat hepatocytes. Biochim Biophys Acta 1981; 663: 83–98
   Google Scholar
• Cheung M. C., Lum K. D., Brouillette C. G., Bisgaier C. L. Characterization of apoA‐I‐containing lipoprotein subpopulations secreted by HepG2 cells. J Lipid Res 1989; 30: 1429–36
   Google Scholar
• Sorci‐Thomas M., Prack M. M., Dashti N., Johnson F., Rudel L. L., Williams D. L. Apolipoprotein (apo) A‐I production and mRNA abundance explain plasma apoA‐I and high density lipoprotein differences between two nonhuman primate species with high and low susceptibilities to diet‐induced hypercholesterolemia. J Biol Chem 1988; 263: 5183–9
   PubMedGoogle Scholar
• Sorci‐Thomas M., Prack M. M., Dashti N., Johnson F., Rudel L. L., Williams D. L. Differential effects of dietary fat on the tissue‐specific expression of the apolipoprotein A‐I gene: relationship to plasma concentration of high density lipoproteins. J Lipid Res 1989; 30: 1397–403
   PubMedGoogle Scholar
• Smith J. D., Miyata M., Ginsberg M., Grigaux C., Shmookler E., Plump A. S. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from macrophage cell line to apolipoprotein acceptors. J Biol Chem 1996; 271: 30647–55
   PubMed Web of Science ®Google Scholar
• Zhang W‐Y., Gaynor P. M., Kruth H. S. Apolipoprotein E produced by human monocyte‐derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors. J Biol Chem 1996; 271: 28641–6
   PubMed Web of Science ®Google Scholar
• Tsujita M., Wu C‐A., Abe‐Dohmae S., Usui S., Okazaki M., Yokoyama S. On the hepatic mechanism of HDL assembly by the ABCA1/apoA‐I pathway. J Lipid Res 2005; 46: 154–62
   PubMed Web of Science ®Google Scholar
• Chisholm J. W., Burleson E. R., Shelness G. S., Parks J. S. ApoA‐I secretion from HepG2 cells: evidence for the secretion of both lipid‐poor apoA‐I and intracellularly assembled nascent HDL. J Lipid Res 2002; 43: 36–44
   PubMed Web of Science ®Google Scholar
• Kiss R. S., McManus D. C., Franklin V., Tan W. L., McKenzie A., Chimini G., et al. The lipidation by hepatocytes of human apolipoprotein A‐I occurs by both ABCA1‐dependent and ‐independent pathways. J Biol Chem 2003; 278: 10119–27
   PubMed Web of Science ®Google Scholar
• Ito J., Zhang L., Asai M., Yokoyama S. Differential generation of high‐density lipoprotein by endogenous and exogenous apolipoproteins in cultured fetal rat astrocytes. J Neurochem 1999; 72: 2362–9
   Google Scholar
• Li Q., Komaba A., Yokoyama S. Cholesterol is poorly available for free apolipoprotein‐mediated cellular lipid efflux from smooth muscle cells. Biochemistry 1993; 32: 4597–603
   Google Scholar
• Jonas A. Reconstitution of high‐density lipoproteins. Methods Enzymol 1986; 128: 553–82
   PubMed Web of Science ®Google Scholar
• von Eckardstein A., Assmann G. High density lipoproteins and reverse cholesterol transport: lessons from mutations. Atherosclerosis 1998; 137: S7–11
   PubMedGoogle Scholar
• Nanjee M. N., Cooke C. J., Olszewski W. L., Miller N. E. Concentrations of electrophoretic and size subclasses of apolipoprotein A‐I‐containing particles in human peripheral lymph. Arterioscler Thromb Vasc Biol 2000; 20: 2148–55
   Google Scholar
• Abe‐Dohmae S., Ikeda Y., Matsuo M., Hayashi M., Okuhira K., Ueda K., et al. Human ABCA7 supports apolipoprotein‐mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein. J Biol Chem 2004; 279: 604–11
   PubMed Web of Science ®Google Scholar
• Wang N., Lan D., Gerbod‐Giannone M., Linsel‐Nitschke P., Jehle A. W., Chen W., et al. ATP‐binding cassette transporter A7 (ABCA7) binds apolipoprotein A‐I and mediates cellular phospholipid but not cholesterol efflux. J Biol Chem 2003; 278: 42906–12
   PubMed Web of Science ®Google Scholar
• Hayashi M., Abe‐Dohmae S., Okazaki M., Ueda K., Yokoyama S. Heterogeneity of high density lipoprotein generated by ABCA1 and ABCA7. J Lipid Res 2005; 46: 1703–11
   Google Scholar
• Abe‐Dohmae S., Kato K. H., Kumon Y., Hu W., Ishigami H., Iwamoto N., et al. Serum amyloid A generates high density lipoprotein with cellular lipid in an ABCA1‐ or ABCA7‐dependent manner. J Lipid Res 2006; 7: 1542–50
   Google Scholar
• Kim W. S., Fitzgerald M. L., Kang K., Okuhira K., Bell S. A., Manning J. J., et al. ABCA7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levels. J Biol Chem 2005; 280: 3989–95
   PubMed Web of Science ®Google Scholar
• Iwamoto N., Abe‐Dohmae S., Sato R., Yokoyama S. ABCA7 expression is regulated by cellular cholesterol through the SREBP2 pathway and associated with phagocytosis. J Lipid Res 2006; 47: 1915–27
   PubMed Web of Science ®Google Scholar
• Assmann G., von Eckardstein A., Brewer HB Jr. Familial Analphalipoproteinemia: Tangier Disease. The Metabolic and Molecular Basis of Inherited Disease, C. R Scriver, A. L Beaudet, D Valle, W. S Sly, C. R Scriver, A. L Beaudet. McGraw‐Hill, New York 2001; 2937–60, 8th ed
   Google Scholar
• Glomset J. A., Assmann G., Gjone E., Norum K. R. Lecithin: cholesterol acyltransferase deficiency and fish eye disease. The Metabolic and Molecular Basis of Inherited Disease, C. R Scriver, A. L Beaudet, W. S Sly, D Valle, C. R Scriver, A. L Beaudet. McGraw‐Hill, Inc. Health Profession Division, New York 1995; 1933–52, 7th ed
   Google Scholar
• Tomimoto S., Tsujita M., Okazaki M., Usui S., Tada T., Fukutomi T., et al. Effect of probucol in lecithin‐cholesterol acyltransferase deficient mice: Inhibition of two independent cellular cholesterol releasing pathways in vivo. Arterioscler Thromb Vasc Biol 2001; 21: 394–400
   Google Scholar